<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03534544</url>
  </required_header>
  <id_info>
    <org_study_id>CHS2018-05</org_study_id>
    <secondary_id>DP3DK113511</secondary_id>
    <nct_id>NCT03534544</nct_id>
  </id_info>
  <brief_title>Patient and Parent Preferences for an On-Body Automated Insulin Delivery System</brief_title>
  <official_title>Patient and Parent Preferences for an On-Body Automated Insulin Delivery System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joslin Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Joslin Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to learn more about patient and family preferences regarding use of&#xD;
      advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of&#xD;
      young persons with type 1 diabetes will complete one study visit involving a semi-structured&#xD;
      interview and surveys. The results of the study will be used to assist in the design of a new&#xD;
      automated insulin delivery system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Type 1 diabetes remains the most common chronic disease of childhood and affects millions of&#xD;
      children and adults globally. The minority of persons with type 1 diabetes achieve the&#xD;
      recommended glycemic targets. Currently approved and unapproved automated insulin delivery&#xD;
      systems require patients to carry and wear multiple devices (pumps, tubing, blood glucose&#xD;
      meters, mobile devices, etc.). There is a need to design automated insulin delivery systems&#xD;
      that reduce the burden of diabetes management for young persons and their families in an&#xD;
      effort to improve glycemic control as well as other biomedical and psychosocial outcomes.&#xD;
&#xD;
      The purpose of this study is to conduct separate semi-structured interviews with young&#xD;
      persons with type 1 diabetes and parents of youth with type 1 diabetes (not necessarily the&#xD;
      parents of the youth participants) regarding their preferences for an automated, on-body&#xD;
      insulin delivery system. Youth and parents will also complete short surveys related to&#xD;
      perceived burden of diabetes self-care, quality of life, acceptance of diabetes, and worries&#xD;
      about hypoglycemia. The feedback received from the interviews and surveys will help inform&#xD;
      the design of a new on-body automated insulin delivery system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 23, 2018</start_date>
  <completion_date type="Actual">December 17, 2019</completion_date>
  <primary_completion_date type="Actual">December 17, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Youth and parent preferences for automated insulin delivery systems</measure>
    <time_frame>1 day</time_frame>
    <description>Semi-structured interviews with young persons with type 1 diabetes and parents; interviews will be transcribed and analyzed to derive central themes; this is a qualitative outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes burden</measure>
    <time_frame>1 day</time_frame>
    <description>Problem Areas in Diabetes survey - Pediatric version (PAID-Peds) and Parent revised version (PAID-PR)&#xD;
PAID-Peds: 20 items, PAID-PR: 18 items&#xD;
Possible score: 0-100&#xD;
Higher score indicates more burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worries about hypoglycemia</measure>
    <time_frame>1 day</time_frame>
    <description>Fear of Hypoglycemia survey - Worry Scale&#xD;
15 items&#xD;
Possible score: 0-100&#xD;
Higher score indicates more worry about hypoglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes acceptance</measure>
    <time_frame>1 day</time_frame>
    <description>Accepting Diabetes and Personal Treatment (ADAPT) survey&#xD;
24 items&#xD;
Scoring methodology will be established with data from this study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 day</time_frame>
    <description>5-Item World Health Organization (WHO-5) Well-Being Index&#xD;
5 items&#xD;
Possible score: 0-100 (percentage score)&#xD;
Higher score indicates better quality of life</description>
  </secondary_outcome>
  <enrollment type="Actual">362</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited from the clinic populations of the 2 study sites.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Young persons (ages 8-25 years) with type 1 diabetes for 1 year or longer&#xD;
&#xD;
          -  Parents of young persons with type 1 diabetes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Laffel, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stuart Weinzimer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eyal Dassau, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Commissariat PV, Volkening LK, Butler DA, Dassau E, Weinzimer SA, Laffel LM. Innovative features and functionalities of an artificial pancreas system: What do youth and parents want? Diabet Med. 2021 Oct;38(10):e14492. doi: 10.1111/dme.14492. Epub 2021 Jan 20.</citation>
    <PMID>33290599</PMID>
  </results_reference>
  <results_reference>
    <citation>Commissariat PV, Roethke LC, Finnegan JL, Guo Z, Volkening LK, Butler DA, Dassau E, Weinzimer SA, Laffel LM. Youth and parent preferences for an ideal AP system: It is all about reducing burden. Pediatr Diabetes. 2021 Nov;22(7):1063-1070. doi: 10.1111/pedi.13252. Epub 2021 Aug 9.</citation>
    <PMID>34324772</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 20, 2018</study_first_submitted>
  <study_first_submitted_qc>May 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Joslin Diabetes Center</investigator_affiliation>
    <investigator_full_name>Lori Laffel</investigator_full_name>
    <investigator_title>Chief, Pediatric, Adolescent, and Young Adult Section; Co-Head, Section on Clinical, Behavioral and Outcomes Research</investigator_title>
  </responsible_party>
  <keyword>artificial pancreas</keyword>
  <keyword>pediatric</keyword>
  <keyword>parents</keyword>
  <keyword>adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Qualitative data may be available after removal of all personal identifiers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

